3 studies found for:
7477169 [PUBMED-IDS]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Safety of Ibritumomab Tiuxetan (Zevalin®) in Combination With a Fludarabine-based Reduced Intensity Conditioning (RIC) Regimen (ZEVALLO 2007)
|
||||
| 2 | Recruiting |
Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
|
||||
| 3 | Recruiting |
The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory Central Nervous System (CNS) Lymphoma
|
† Indicates status has not been verified in more than two years